Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 179 articles:
HTML format
Text format



Single Articles


    January 2019
  1. MATTSSON N, Insel PS, Donohue M, Jogi J, et al
    Predicting diagnosis and cognition with (18)F-AV-1451 tau PET and structural MRI in Alzheimer's disease.
    Alzheimers Dement. 2019 Jan 9. pii: S1552-5260(18)33605.
    PubMed     Text format     Abstract available


  2. THOMAS KR, Eppig JS, Weigand AJ, Edmonds EC, et al
    Artificially low mild cognitive impairment to normal reversion rate in Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2019 Jan 2. pii: S1552-5260(18)33603.
    PubMed     Text format     Abstract available


  3. MCCLEERY J, Flicker L, Richard E, Quinn TJ, et al
    The National Institute on Aging and Alzheimer's Association research framework: A commentary from the Cochrane Dementia and Cognitive Improvement Group.
    Alzheimers Dement. 2019;15:179-181.
    PubMed     Text format    


  4. SWEENEY MD, Montagne A, Sagare AP, Nation DA, et al
    Vascular dysfunction-The disregarded partner of Alzheimer's disease.
    Alzheimers Dement. 2019;15:158-167.
    PubMed     Text format     Abstract available


  5. JAGUST W, Jack CR Jr, Bennett DA, Blennow K, et al
    "Alzheimer's disease" is neither "Alzheimer's clinical syndrome" nor "dementia".
    Alzheimers Dement. 2019;15:153-157.
    PubMed     Text format    


    December 2018
  6. SLOT RER, Sikkes SAM, Berkhof J, Brodaty H, et al
    Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33563.
    PubMed     Text format     Abstract available


  7. BABULAL GM, Quiroz YT, Albensi BC, Arenaza-Urquijo E, et al
    Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
    Alzheimers Dement. 2018 Dec 13. pii: S1552-5260(18)33556.
    PubMed     Text format     Abstract available


    November 2018
  8. ZHANG X, Zhu C, Beecham G, Vardarajan BN, et al
    A rare missense variant of CASP7 is associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 29. pii: S1552-5260(18)33579.
    PubMed     Text format     Abstract available


  9. XIONG F, Ge W, Ma C
    Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 28. pii: S1552-5260(18)33580.
    PubMed     Text format     Abstract available


  10. BELL WR, An Y, Kageyama Y, English C, et al
    Neuropathologic, genetic, and longitudinal cognitive profiles in primary age-related tauopathy and Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33483.
    PubMed     Text format     Abstract available


  11. LATIMER CS, Shively CA, Keene CD, Jorgensen MJ, et al
    A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis.
    Alzheimers Dement. 2018 Nov 19. pii: S1552-5260(18)33246.
    PubMed     Text format     Abstract available


  12. STARTIN CM, Hamburg S, Hithersay R, Al-Janabi T, et al
    Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.
    Alzheimers Dement. 2018 Nov 15. pii: S1552-5260(18)33518.
    PubMed     Text format     Abstract available


  13. CHEN Z, Mengel D, Keshavan A, Rissman RA, et al
    Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
    Alzheimers Dement. 2018 Nov 9. pii: S1552-5260(18)33561.
    PubMed     Text format     Abstract available


  14. ISAACSON RS, Ganzer CA, Hristov H, Hackett K, et al
    The clinical practice of risk reduction for Alzheimer's disease: A precision medicine approach.
    Alzheimers Dement. 2018 Nov 5. pii: S1552-5260(18)33513.
    PubMed     Text format     Abstract available


    October 2018
  15. PALMQVIST S, Insel PS, Zetterberg H, Blennow K, et al
    Accurate risk estimation of beta-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
    Alzheimers Dement. 2018 Oct 23. pii: S1552-5260(18)33524.
    PubMed     Text format     Abstract available


  16. JOIE R, Ayakta N, Seeley WW, Borys E, et al
    Multisite study of the relationships between antemortem [(11)C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Oct 19. pii: S1552-5260(18)33523.
    PubMed     Text format     Abstract available


  17. NHO K, Kueider-Paisley A, MahmoudianDehkordi S, Arnold M, et al
    Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
    Alzheimers Dement. 2018 Oct 15. pii: S1552-5260(18)33521.
    PubMed     Text format     Abstract available


  18. HU X, Teunissen C, Spottke A, Heneka MT, et al
    Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer's disease-Data from three memory clinic studies.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33527.
    PubMed     Text format     Abstract available


  19. VEITCH DP, Weiner MW, Aisen PS, Beckett LA, et al
    Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33514.
    PubMed     Text format     Abstract available


  20. HUANG F, Wang M, Liu R, Wang JZ, et al
    CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33522.
    PubMed     Text format     Abstract available


  21. SANDELIUS A, Portelius E, Kallen A, Zetterberg H, et al
    Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
    Alzheimers Dement. 2018 Oct 12. pii: S1552-5260(18)33515.
    PubMed     Text format     Abstract available


  22. MOIR RD, Lathe R, Tanzi RE
    The antimicrobial protection hypothesis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 9. pii: S1552-5260(18)33228.
    PubMed     Text format     Abstract available


  23. MAHMOUDIANDEHKORDI S, Arnold M, Nho K, Ahmad S, et al
    Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
    Alzheimers Dement. 2018 Oct 8. pii: S1552-5260(18)33486.
    PubMed     Text format     Abstract available


  24. SHAW LM, Arias J, Blennow K, Galasko D, et al
    Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Oct 3. pii: S1552-5260(18)33492.
    PubMed     Text format     Abstract available


  25. KODIS EJ, Choi S, Swanson E, Ferreira G, et al
    N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-beta oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Alzheimers Dement. 2018;14:1302-1312.
    PubMed     Text format     Abstract available


    September 2018
  26. MULLER S, Preische O, Sohrabi HR, Graber S, et al
    Relationship between physical activity, cognition, and Alzheimer pathology in autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 21. pii: S1552-5260(18)33248.
    PubMed     Text format     Abstract available


  27. RASMUSSEN KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, et al
    An updated Alzheimer hypothesis: Complement C3 and risk of Alzheimer's disease-A cohort study of 95,442 individuals.
    Alzheimers Dement. 2018 Sep 19. pii: S1552-5260(18)33496.
    PubMed     Text format     Abstract available


  28. LIN YF, Smith AV, Aspelund T, Betensky RA, et al
    Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms.
    Alzheimers Dement. 2018 Sep 18. pii: S1552-5260(18)33493.
    PubMed     Text format     Abstract available


  29. MATTHEWS KA, Xu W, Gaglioti AH, Holt JB, et al
    Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >/=65 years.
    Alzheimers Dement. 2018 Sep 17. pii: S1552-5260(18)33252.
    PubMed     Text format     Abstract available


  30. SASAKI S
    High prevalence of parkinsonism in patients with MCI or mild Alzheimer's disease.
    Alzheimers Dement. 2018 Sep 14. pii: S1552-5260(18)33243.
    PubMed     Text format     Abstract available


  31. RAJAN KB, Weuve J, Barnes LL, Wilson RS, et al
    Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study.
    Alzheimers Dement. 2018 Sep 6. pii: S1552-5260(18)33484.
    PubMed     Text format     Abstract available


  32. CAVEDO E, Chiesa PA, Houot M, Ferretti MT, et al
    Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints.
    Alzheimers Dement. 2018;14:1204-1215.
    PubMed     Text format     Abstract available


  33. BEYDOUN MA, Beydoun HA, Elbejjani M, Dore GA, et al
    Helicobacter pylori seropositivity and its association with incident all-cause and Alzheimer's disease dementia in large national surveys.
    Alzheimers Dement. 2018;14:1148-1158.
    PubMed     Text format     Abstract available


  34. MIELKE MM, Ferretti MT, Iulita MF, Hayden K, et al
    Sex and gender in Alzheimer's disease - Does it matter?
    Alzheimers Dement. 2018;14:1101-1103.
    PubMed     Text format    


    August 2018
  35. NICOLAS G, Acuna-Hidalgo R, Keogh MJ, Quenez O, et al
    Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 13. pii: S1552-5260(18)33245.
    PubMed     Text format     Abstract available


  36. TANG Y, Lutz MW, Xing Y
    A systems-based model of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 10. pii: S1552-5260(18)33247.
    PubMed     Text format     Abstract available


  37. LEE CS, Larson EB, Gibbons LE, Lee AY, et al
    Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.
    Alzheimers Dement. 2018 Aug 2. pii: S1552-5260(18)33034.
    PubMed     Text format     Abstract available


    July 2018
  38. VERGALLO A, Bun RS, Toschi N, Baldacci F, et al
    Association of cerebrospinal fluid alpha-synuclein with total and phospho-tau181 protein concentrations and brain amyloid load in cognitively normal subjective memory complainers stratified by Alzheimer's disease biomarkers.
    Alzheimers Dement. 2018 Jul 25. pii: S1552-5260(18)33241.
    PubMed     Text format     Abstract available


    June 2018
  39. RUTHIRAKUHAN M, Lanctot KL, Di Scipio M, Ahmed M, et al
    Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30157.
    PubMed     Text format     Abstract available


  40. HANSSON O, Mikulskis A, Fagan AM, Teunissen C, et al
    The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30162.
    PubMed     Text format     Abstract available


  41. YOO HS, Jeon S, Chung SJ, Evans AC, et al
    Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30164.
    PubMed     Text format     Abstract available


  42. CUMMINGS J
    The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30160.
    PubMed     Text format     Abstract available


    May 2018
  43. NEBEL RA, Aggarwal NT, Barnes LL, Gallagher A, et al
    Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
    Alzheimers Dement. 2018 May 31. pii: S1552-5260(18)30130.
    PubMed     Text format     Abstract available


  44. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
    Alzheimers Dement. 2018 May 26. pii: S1552-5260(18)30155.
    PubMed     Text format    


  45. BUCKLEY RF, Mormino EC, Amariglio RE, Properzi MJ, et al
    Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
    Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132.
    PubMed     Text format     Abstract available


  46. TEIPEL SJ, Cavedo E, Lista S, Habert MO, et al
    Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30126.
    PubMed     Text format     Abstract available


  47. JOHANSSON JU, Brubaker WD, Javitz H, Bergen AW, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30125.
    PubMed     Text format     Abstract available


  48. SAEED U, Mirza SS, MacIntosh BJ, Herrmann N, et al
    APOE-epsilon4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Alzheimers Dement. 2018 May 18. pii: S1552-5260(18)30127.
    PubMed     Text format     Abstract available


  49. IWATSUBO T, Iwata A, Suzuki K, Ihara R, et al
    Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Alzheimers Dement. 2018 May 8. pii: S1552-5260(18)30102.
    PubMed     Text format     Abstract available


  50. BROOKMEYER R, Abdalla N
    Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Alzheimers Dement. 2018 May 7. pii: S1552-5260(18)30098.
    PubMed     Text format     Abstract available


  51. LI P, Yu L, Lim ASP, Buchman AS, et al
    Fractal regulation and incident Alzheimer's disease in elderly individuals.
    Alzheimers Dement. 2018 May 4. pii: S1552-5260(18)30108.
    PubMed     Text format     Abstract available


    April 2018
  52. MIELKE MM, Hagen CE, Xu J, Chai X, et al
    Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
    Alzheimers Dement. 2018 Apr 4. pii: S1552-5260(18)30067.
    PubMed     Text format     Abstract available


  53. SILVERBERG N, Elliott C, Ryan L, Masliah E, et al
    NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:576-578.
    PubMed     Text format    


  54. KNOPMAN DS, Haeberlein SB, Carrillo MC, Hendrix JA, et al
    The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Alzheimers Dement. 2018;14:563-575.
    PubMed     Text format     Abstract available


  55. JACK CR JR., Bennett DA, Blennow K, Carrillo MC, et al
    NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:535-562.
    PubMed     Text format     Abstract available


  56. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Alzheimers Dement. 2018;14:532-534.
    PubMed     Text format    


    March 2018
  57. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30074.
    PubMed     Text format     Abstract available


  58. DARWEESH SKL, Wolters FJ, Ikram MA, de Wolf F, et al
    Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30068.
    PubMed     Text format     Abstract available


  59. VERMUNT L, Veal CD, Meulen LT, Chrysostomou C, et al
    European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30064.
    PubMed     Text format     Abstract available


  60. SHI M, Tang L, Toledo JB, Ginghina C, et al
    Cerebrospinal fluid alpha-synuclein contributes to the differential diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30069.
    PubMed     Text format     Abstract available


  61. CACCIAGLIA R, Molinuevo JL, Falcon C, Brugulat-Serrat A, et al
    Effects of APOE-epsilon4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30044.
    PubMed     Text format     Abstract available


  62. MATTSSON N, Groot C, Jansen WJ, Landau S, et al
    Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30063.
    PubMed     Text format     Abstract available


  63. SUTPHEN CL, McCue L, Herries EM, Xiong C, et al
    Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30031.
    PubMed     Text format     Abstract available


  64. GOLDMAN DP, Fillit H, Neumann P
    Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30050.
    PubMed     Text format     Abstract available


  65. STITES SD, Rubright JD, Karlawish J
    What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.
    Alzheimers Dement. 2018 Mar 17. pii: S1552-5260(18)30025.
    PubMed     Text format     Abstract available


  66. SMITH RG, Hannon E, De Jager PL, Chibnik L, et al
    Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Mar 14. pii: S1552-5260(18)30049.
    PubMed     Text format     Abstract available


  67. CONNORS MH, Seeher KM, Crawford J, Ames D, et al
    The stability of neuropsychiatric subsyndromes in Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 13. pii: S1552-5260(18)30048.
    PubMed     Text format     Abstract available


  68. CHIBA-FALEK O, Gottschalk WK, Lutz MW
    The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Alzheimers Dement. 2018 Mar 7. pii: S1552-5260(18)30043.
    PubMed     Text format     Abstract available


    February 2018
  69. TYNKKYNEN J, Chouraki V, van der Lee SJ, Hernesniemi J, et al
    Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.
    Alzheimers Dement. 2018 Feb 28. pii: S1552-5260(18)30020.
    PubMed     Text format     Abstract available


  70. HANSSON O, Seibyl J, Stomrud E, Zetterberg H, et al
    CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Alzheimers Dement. 2018 Feb 27. pii: S1552-5260(18)30029.
    PubMed     Text format     Abstract available


  71. AHMAD S, Bannister C, van der Lee SJ, Vojinovic D, et al
    Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study.
    Alzheimers Dement. 2018 Feb 26. pii: S1552-5260(18)30024.
    PubMed     Text format     Abstract available


  72. COHEN AD, McDade E, Christian B, Price J, et al
    Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
    Alzheimers Dement. 2018 Feb 22. pii: S1552-5260(18)30019.
    PubMed     Text format     Abstract available


  73. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Alzheimers Dement. 2018 Feb 16. pii: S1552-5260(18)30021.
    PubMed     Text format     Abstract available


  74. KNOPMAN DS, Siemers ER, Bain LJ, Hendrix JA, et al
    National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Alzheimers Dement. 2018;14:261-262.
    PubMed     Text format    


    January 2018
  75. MIRON J, Picard C, Nilsson N, Frappier J, et al
    CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Jan 19. pii: S1552-5260(17)33875.
    PubMed     Text format     Abstract available


  76. DI GUARDO G
    Alzheimer's disease, cellular prion protein, and dolphins.
    Alzheimers Dement. 2018 Jan 15. pii: S1552-5260(17)33873.
    PubMed     Text format    


  77. JIA J, Wei C, Chen S, Li F, et al
    The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Alzheimers Dement. 2018 Jan 11. pii: S1552-5260(17)33877.
    PubMed     Text format     Abstract available


  78. HAMPEL H, Toschi N, Baldacci F, Zetterberg H, et al
    Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33872.
    PubMed     Text format     Abstract available


  79. TSE KH, Cheng A, Ma F, Herrup K, et al
    DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33853.
    PubMed     Text format     Abstract available


  80. ACOSTA D, Powell F, Zhao Y, Raj A, et al
    Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.
    Alzheimers Dement. 2018 Jan 4. pii: S1552-5260(17)33857.
    PubMed     Text format     Abstract available


  81. LI K, O'Brien R, Lutz M, Luo S, et al
    A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
    Alzheimers Dement. 2018 Jan 3. pii: S1552-5260(17)33840.
    PubMed     Text format     Abstract available


    December 2017
  82. HALL H, Iulita MF, Gubert P, Aguilar LF, et al
    AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 29. pii: S1552-5260(17)33851.
    PubMed     Text format     Abstract available


  83. CHUNG J, Wang X, Maruyama T, Ma Y, et al
    Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.
    Alzheimers Dement. 2017 Dec 20. pii: S1552-5260(17)33842.
    PubMed     Text format     Abstract available


  84. LEUZY A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, et al
    Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 18. pii: S1552-5260(17)33844.
    PubMed     Text format     Abstract available


  85. BECKER RE, Kapogiannis D, Greig NH
    Does traumatic brain injury hold the key to the Alzheimer's puzzle?
    Alzheimers Dement. 2017 Dec 12. pii: S1552-5260(17)33843.
    PubMed     Text format     Abstract available


  86. PASPALAS CD, Carlyle BC, Leslie S, Preuss TM, et al
    The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.
    Alzheimers Dement. 2017 Dec 11. pii: S1552-5260(17)33841.
    PubMed     Text format     Abstract available


    November 2017
  87. BROOKMEYER R, Abdalla N, Kawas CH, Corrada MM, et al
    Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Alzheimers Dement. 2017 Nov 29. pii: S1552-5260(17)33813.
    PubMed     Text format     Abstract available


  88. STEFANIAK JD, Su L, Mak E, Bahaei NS, et al
    Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Nov 18. pii: S1552-5260(17)33809.
    PubMed     Text format     Abstract available


  89. VIDONI ED, Bothwell RJ, Burns JM, Dwyer JR, et al
    Novel recruitment models will drive Alzheimer's trial success.
    Alzheimers Dement. 2017 Nov 17. pii: S1552-5260(17)33793.
    PubMed     Text format    


    October 2017
  90. MONTAL V, Vilaplana E, Alcolea D, Pegueroles J, et al
    Cortical microstructural changes along the Alzheimer's disease continuum.
    Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33767.
    PubMed     Text format     Abstract available


  91. ALLEN M, Wang X, Burgess JD, Watzlawik J, et al
    Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33766.
    PubMed     Text format     Abstract available


  92. CRANE PK, Foroud T, Montine TJ, Larson EB, et al
    Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33764.
    PubMed     Text format     Abstract available


  93. AN Y, Varma VR, Varma S, Casanova R, et al
    Evidence for brain glucose dysregulation in Alzheimer's disease.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33765.
    PubMed     Text format     Abstract available


  94. HAMPEL H, Mesulam MM, Cuello AC, Khachaturian AS, et al
    Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.
    Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719.
    PubMed     Text format     Abstract available


    September 2017
  95. GUNN-MOORE D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, et al
    Alzheimer's disease in humans and other animals-A consequence of postreproductive life span and longevity rather than aging.
    Alzheimers Dement. 2017 Sep 30. pii: S1552-5260(17)33717.
    PubMed     Text format     Abstract available


  96. CRUCHAGA C, Del-Aguila JL, Saef B, Black K, et al
    Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.
    Alzheimers Dement. 2017 Sep 21. pii: S1552-5260(17)33708.
    PubMed     Text format     Abstract available


  97. XU M, Zhang DF, Luo R, Wu Y, et al
    A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 15. pii: S1552-5260(17)33707.
    PubMed     Text format     Abstract available


  98. GEERTS H, Hofmann-Apitius M, Anastasio TJ
    Knowledge-driven computational modeling in Alzheimer's research: Current state and future trends.
    Alzheimers Dement. 2017 Sep 14. pii: S1552-5260(17)33690.
    PubMed     Text format     Abstract available


  99. LIN PJ, Zhong Y, Fillit HM, Cohen JT, et al
    Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 5. pii: S1552-5260(17)33687.
    PubMed     Text format     Abstract available


    August 2017
  100. KNOPMAN D, Alford E, Tate K, Long M, et al
    Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Alzheimers Dement. 2017;13:940-946.
    PubMed     Text format     Abstract available


  101. WOLF D, Bocchetta M, Preboske GM, Boccardi M, et al
    Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry.
    Alzheimers Dement. 2017;13:893-902.
    PubMed     Text format     Abstract available


  102. GRILL JD, Cox CG, Kremen S, Mendez MF, et al
    Patient and caregiver reactions to clinical amyloid imaging.
    Alzheimers Dement. 2017;13:924-932.
    PubMed     Text format     Abstract available


    July 2017
  103. CRANE A, Brubaker WD, Johansson JU, Trigunaite A, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: 2. Relationship to Abeta immunotherapy.
    Alzheimers Dement. 2017 Jul 26. pii: S1552-5260(17)32898.
    PubMed     Text format     Abstract available


  104. LUTSEY PL, Misialek JR, Mosley TH, Gottesman RF, et al
    Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32522.
    PubMed     Text format     Abstract available


  105. KINNUNEN KM, Cash DM, Poole T, Frost C, et al
    Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32521.
    PubMed     Text format     Abstract available


  106. FRAIN L, Swanson D, Cho K, Gagnon D, et al
    Association of cancer and Alzheimer's disease risk in a national cohort of veterans.
    Alzheimers Dement. 2017 Jul 12. pii: S1552-5260(17)30218.
    PubMed     Text format     Abstract available


  107. BURGGREN AC, Mahmood Z, Harrison TM, Siddarth P, et al
    Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE epsilon4 variant.
    Alzheimers Dement. 2017;13:739-748.
    PubMed     Text format     Abstract available


    June 2017
  108. CRANE PK, Trittschuh E, Mukherjee S, Saykin AJ, et al
    Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.
    Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216.
    PubMed     Text format     Abstract available


  109. DRACHMAN DA, Smith TW, Alkamachi B, Kane K, et al
    Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219.
    PubMed     Text format     Abstract available


  110. CHOURAKI V, Preis SR, Yang Q, Beiser A, et al
    Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Alzheimers Dement. 2017 Jun 8. pii: S1552-5260(17)30200.
    PubMed     Text format     Abstract available


  111. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Text format     Abstract available


  112. PASCOAL TA, Mathotaarachchi S, Shin M, Benedet AL, et al
    Synergistic interaction between amyloid and tau predicts the progression to dementia.
    Alzheimers Dement. 2017;13:644-653.
    PubMed     Text format     Abstract available


  113. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.
    Alzheimers Dement. 2017;13:654-662.
    PubMed     Text format     Abstract available


  114. SCHELLE J, Hasler LM, Gopfert JC, Joos TO, et al
    Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.
    Alzheimers Dement. 2017;13:701-709.
    PubMed     Text format     Abstract available


    May 2017
  115. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Text format     Abstract available


  116. WILLETTE AA, Webb JL, Lutz MW, Bendlin BB, et al
    Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Alzheimers Dement. 2017 May 10. pii: S1552-5260(17)30148.
    PubMed     Text format     Abstract available


  117. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Text format     Abstract available


  118. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Text format     Abstract available


    April 2017
  119. CARMONA-IRAGUI M, Balasa M, Benejam B, Alcolea D, et al
    Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2017 Apr 29. pii: S1552-5260(17)30146.
    PubMed     Text format     Abstract available


  120. CARRILLO MC, Fillit H, Ganguli M, Knopman D, et al
    Letter to the Editor re: Nexus of Cancer & Alzheimer's.
    Alzheimers Dement. 2017 Apr 19. pii: S1552-5260(17)30142.
    PubMed     Text format    


  121. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Text format     Abstract available


    March 2017
  122. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Text format     Abstract available


  123. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Text format     Abstract available


  124. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Text format     Abstract available


  125. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Text format     Abstract available


  126. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Text format     Abstract available


  127. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Text format     Abstract available


  128. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Text format     Abstract available


  129. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Text format     Abstract available


  130. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Text format     Abstract available


  131. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Text format     Abstract available


  132. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.
    PubMed     Text format    


  133. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Text format     Abstract available


  134. SIMONSEN AH, Herukka SK, Andreasen N, Baldeiras I, et al
    Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
    Alzheimers Dement. 2017;13:274-284.
    PubMed     Text format     Abstract available


  135. TON TGN, DeLeire T, May SG, Hou N, et al
    The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
    Alzheimers Dement. 2017;13:217-224.
    PubMed     Text format     Abstract available


    February 2017
  136. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Text format     Abstract available


  137. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Text format     Abstract available


  138. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Text format     Abstract available


  139. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Text format     Abstract available


  140. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed     Text format    


  141. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Text format     Abstract available


  142. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Text format     Abstract available


  143. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Text format     Abstract available


  144. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Text format     Abstract available


  145. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Text format     Abstract available


  146. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Text format     Abstract available


  147. OVERK C, Masliah E
    Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease.
    Alzheimers Dement. 2017;13:183-185.
    PubMed     Text format    


    January 2017
  148. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Text format     Abstract available


  149. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.
    PubMed     Text format    


  150. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Text format     Abstract available


  151. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Text format     Abstract available


  152. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Text format     Abstract available



  153. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Text format     Abstract available


    December 2016
  154. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Text format     Abstract available


  155. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Text format     Abstract available


  156. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Text format     Abstract available


  157. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Text format     Abstract available


    November 2016
  158. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Text format     Abstract available


  159. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Text format     Abstract available


  160. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Text format     Abstract available


  161. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.
    PubMed     Text format    


    October 2016
  162. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Text format     Abstract available


  163. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Text format     Abstract available


  164. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Text format     Abstract available


  165. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Text format     Abstract available


  166. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Text format     Abstract available


  167. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Text format     Abstract available


    September 2016
  168. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Text format     Abstract available


  169. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Text format     Abstract available


  170. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Text format     Abstract available


  171. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Text format     Abstract available


  172. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Text format     Abstract available


  173. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Text format     Abstract available


  174. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Text format     Abstract available


  175. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Text format     Abstract available


    April 2016
  176. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Text format     Abstract available


  177. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Text format     Abstract available


    February 2016
  178. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Text format     Abstract available


  179. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: